Nerve News and Research

RSS

Proteomics yields new drug targets for treating cardiogenic shock

When it comes to cell signaling and bioregulation, it's tough to find a more important molecule than nitric oxide (NO). Dysfunction of NO-mediated signaling is thought to be a culprit in lethal cardiovascular conditions such as angina, and septic, cardiogenic and hemorrhagic shock; it may play a role in many other illnesses as well.

3 Apr 2006

Radical prostatectomy QoL outcomes can be obtained in single-surgeon practices

Most often urologists cite radical prostatectomy (RP) outcomes from large studies and high volume centers. However, these may not accurately reflect the outcomes of individual surgeons.

30 Mar 2006

Mustard and garlic kick linked to single pain receptor

A single pain receptor is solely responsible for the kick delivered by mustard oil and garlic, according to research in the Cell. Mustard oil is the active ingredient in mustard and in the pungent green sushi condiment known as wasabi.

28 Mar 2006

Cell therapy slows progression of metachromatic leukodystrophy

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants.

23 Mar 2006

Zinc's role in Alzheimer's disease

Zinc may be a familiar dietary supplement to millions of health-conscious people, but it remains a mystery metal to scientists who study zinc's role in Alzheimer's disease, stroke and other health problems.

23 Mar 2006

Hip surgery in the elderly and obese, orthopaedic research emphasizes need for complete preoperative assessments

As many Americans continue to grow older, another large part of the population is faced with the growing problem of obesity: both of these conditions can adversely impact mobility and ultimately, patients' independence.

23 Mar 2006

Stem cells, gene therapy and allograft applications show promise for treating orthopaedic conditions

Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.

23 Mar 2006

Yale researchers shed new light on the mechanism of nerve cell growth

Researchers at Yale shed new light on the mechanism of nerve cell growth by identifying novel functions for a molecular "motor" protein, myosin-II, according to an article in Nature Cell Biology.

20 Mar 2006

Atorvastatin could prove an effective therapy for multiple sclerosis

Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).

20 Mar 2006

Researcher identifies the cellular receptor for botulinum neurotoxin A

Botulinum neurotoxin A can be either the greatest wrinkle remover or one of the world's most potent biological weapons. To perform either job, however, the toxin must first find a way to enter cells.

20 Mar 2006

Discovery of substance in the brain that is proven to cause memory loss

Researchers at the University of Minnesota Medical School and the Minneapolis VA Medical Center have for the first time identified a substance in the brain that is proven to cause memory loss.

19 Mar 2006

Protein complex in brain may be key to Alzheimer's

Scientists in the U.S. say they have discovered a substance in the brain of mice that causes memory loss; they believe the discovery gives drug developers a target for creating drugs to treat memory loss in people with dementia.

16 Mar 2006

Valproic acid may help slow the progression of dementia

Researchers have found that a common anticonvulsant drug improved cognitive function and appeared to restore nerve cells in the brains of patients with HIV-related dementia. The results of the Phase I clinical trial are published in the March issue of the scientific journal Neurology.

14 Mar 2006

Third U.S. case of mad cow disease

According to the U.S. Department of Agriculture routine tests have revealed a third U.S. case of mad cow disease.

13 Mar 2006

Scientists exploit novel route to reverse enlarged hearts in obese mice

Working on genetically engineered obese mice with seriously thickened hearts, a condition call cardiac hypertrophy, scientists at Johns Hopkins have used a nerve protection and growth factor on the heart to mimic the activity of the brain hormone leptin, dramatically reducing the size of the heart muscle.

13 Mar 2006